No Myth: CEO of ADC up­start calls it quits; Bris­tol My­ers vet Jon Wig­gin­ton scales new heights at Bright Peak

→ When Myth­ic Ther­a­peu­tics CEO Alex Nichols spoke to End­points News last De­cem­ber about the biotech’s $103 mil­lion Se­ries B, he and fel­low co-founder Bri­an Fiske em­pha­sized safe­ty, say­ing that they’re “re­al­ly work­ing on try­ing to over­come what has been one of the most his­tor­i­cal­ly chal­leng­ing ob­sta­cles to re­al­iz­ing the full po­ten­tial of AD­Cs.” But Myth­ic will have to look for some­one else to take up that man­tle.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER